MarketInOut Stock Screener Log In | Sign Up

Celltrion Pharm Inc

KRX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:30
Celltrion Pharm Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization1,617,633 mln
Float19.14 mln
Earnings Date08/18/2025

EPS

968
Exceptional

P / E

38.48
Overvalued

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-2.49
Borderline

Relative Strength

70 / 100
Outperforming

Debt / Equity

0.36
Low leverage

Business Description

Celltrion Pharm Inc. is a South Korea-based subsidiary of Celltrion Inc., founded in 1976 and listed on the KOSDAQ exchange. The company manufactures and distributes a broad range of medicines, including biosimilars and consumer health products, covering areas such as immunity, oncology, digestion, respiratory health, and infectious disease. Its products reach patients through university hospitals and retail pharmacies across the country, with operations headquartered in Cheongju-si.

Key Fundamentals

EPS968
P/E38.48
ROE9.92
RPS6,192
ROIC8.73
ROA5.67
Interest Cover9.83
EBITDA, mln85,743
EV / EBITDA19.77
EV / EBIT27.22
Revenue, mln577,991
EV / Revenue2.93

Quote Details

Last 37,100
Change 550 (1.5%)
Open 36,700
Volume 33,759
Turnover 1,252,458,880
Average Volume 71,555

Financial Ratios

Pre-Tax Profit Margin10
Leverage Ratio1.74
Current Ratio1.71
Price / Book3.75
Price / Tangible Book4.34
Price / Cash Flow94.01
Price / Free Cash Flow36.04
Debt / Equity0.36
Price / Sales2.92
PEG Ratio3.67

Financial Strength

Altman Z-Score4.64
Piotroski F-Score 9 / 9
Beneish M-Score-2.49
Price to Intrinsic Value2.13
Price to Lynch Fair Value6.25
Price to Graham Number2.75
Shiller PE Ratio98.88

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.72% 19 / 100   
1 Month -4.99% 55 / 100   
2 Months -6.78% 43 / 100   
6 Months -35.48% 31 / 100   
1 Year -31.96% 27 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog